الفهرس 
Normal breast anatomyOnly 14 pages are availabe for public view
 |  | from | 193 |  |  |
| | | from | 193 | | |
Abstract
SUMMARY
The study was done to evaluate the accuracy of integrated positron
emission tomography and computed tomography (PET/CT) using 18Ffluorodeoxyglucose
(FDG), for follow-up of patients with suspected
recurrent breast cancer.
Approximately 1 in 10 women will suffer from breast cancer
during their lifetime. Among malignancies, breast cancer is the second
cause of death in women after lung cancer.
Early detection is the most effective strategy for reducing
mortality from breast cancer. Mammography is the only screening
method that has been shown to affect patient survival.
The study was conducted on 30 female patients with past history
of breast cancer .The patient’s ages were between 31-75 years old, who
had whole-body 18F- FDG PET/CT.
Our study suggests that;
1) PET/CT is an accurate, sensitive and reliable modality for
screening and detection of breast cancer recurrence.
2) PET/CT appears to be an effective surveillance tool, as it is able to
cover the whole body in a single procedure and shows good
performance.
3) True FDG uptake is underestimated in small cancer deposits
because of the limited spatial resolution of current PET devices.
4) FDG/PET has been shown to be of limited rule in detecting
osteoblastic bone metastases due to hypometabolic activity of the
lesions.
5) FDG PET/CT is likely to be more useful as a screening test for
distant metastases in patients with an advanced stage of breast
cancer than in those with an early stage.